+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type , By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 111 Pages
  • March 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953477
The North America Hyperpigmentation Treatment Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030).

The US market dominated the North America Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,287.3 million by 2030. The Canada market is experiencing a CAGR of 9.8% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 8.9% during (2023 - 2030).



The trend toward personalized skincare regimens has permeated the hyperpigmentation treatment market. Consumers increasingly seek treatments tailored to their skin types, concerns, and lifestyles. The availability of personalized treatment plans, incorporating a mix of topical formulations, laser therapies, and other interventions, enhances the overall efficacy of hyperpigmentation treatments and fosters a sense of individualized care. The psychological and aesthetic impact of hyperpigmentation on an individual’s confidence and self-esteem is a significant driver for adoption. As societal attitudes shift towards recognizing the importance of mental well-being and self-confidence, more people are actively seeking solutions to address pigmentation concerns, viewing these treatments as improving their skin’s appearance and overall quality of life.

It is associated with hormonal fluctuations, pregnancy, and the sun exposure, melasma is a prevalent skin condition characterized by dark patches, which frequently appear on the face. Hyperpigmentation treatments are frequently employed to lighten these dark patches and improve overall skin tone. PIH occurs because of skin inflammation, such as acne or other injuries. Hyperpigmentation treatments help reduce the discoloration left behind after the inflammatory process, promoting a more even skin tone. Sunspots, age spots, or hyperpigmentation areas can form due to prolonged sun exposure.

According to the Canadian Institute for Health Information, Canada’s senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Market Report Segmentation

By Treatment Type
  • Topical Agent
  • Photo Therapy
  • Microdermabrasion
By End User
  • Dermatological Clinics
  • Hospitals
  • Others
By Disorder Type
  • Melasma
  • Age Spot
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hyperpigmentation Treatment Market, by Treatment Type
1.4.2 North America Hyperpigmentation Treatment Market, by End User
1.4.3 North America Hyperpigmentation Treatment Market, by Disorder Type
1.4.4 North America Hyperpigmentation Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Hyperpigmentation Treatment Market by Treatment Type
4.1 North America Topical Agent Market by Country
4.2 North America Photo Therapy Market by Country
4.3 North America Microdermabrasion Market by Country
Chapter 5. North America Hyperpigmentation Treatment Market by End User
5.1 North America Dermatological Clinics Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Hyperpigmentation Treatment Market by Disorder Type
6.1 North America Melasma Market by Country
6.2 North America Age Spot Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Hyperpigmentation Treatment Market by Country
7.1 US Hyperpigmentation Treatment Market
7.1.1 US Hyperpigmentation Treatment Market by Treatment Type
7.1.2 US Hyperpigmentation Treatment Market by End User
7.1.3 US Hyperpigmentation Treatment Market by Disorder Type
7.2 Canada Hyperpigmentation Treatment Market
7.2.1 Canada Hyperpigmentation Treatment Market by Treatment Type
7.2.2 Canada Hyperpigmentation Treatment Market by End User
7.2.3 Canada Hyperpigmentation Treatment Market by Disorder Type
7.3 Mexico Hyperpigmentation Treatment Market
7.3.1 Mexico Hyperpigmentation Treatment Market by Treatment Type
7.3.2 Mexico Hyperpigmentation Treatment Market by End User
7.3.3 Mexico Hyperpigmentation Treatment Market by Disorder Type
7.4 Rest of North America Hyperpigmentation Treatment Market
7.4.1 Rest of North America Hyperpigmentation Treatment Market by Treatment Type
7.4.2 Rest of North America Hyperpigmentation Treatment Market by End User
7.4.3 Rest of North America Hyperpigmentation Treatment Market by Disorder Type
Chapter 8. Company Profiles
8.1 Vivier Pharma Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Pierre Fabre S.A
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.3 SWOT Analysis
8.3 Aerolase
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 L'Oréal S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.5 SWOT Analysis
8.5 The Procter & Gamble Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Galderma S.A.
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 CP Skin Health Group, Inc. (The Colgate Palmolive Company)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Trophy Skin Products LLC
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Episciences, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis

Companies Mentioned

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Methodology

Loading
LOADING...